Bradycardia associated with ophthalmic beta-blockers [1]

Journal of Postgraduate Medicine

Volumn 49, Issue 2, 2003, Pages 186-

  Calvo Romero, J M ^a   Lima Rodriguez E M ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; ENALAPRIL; EYE DROPS; LATANOPROST; TIMOLOL;

ADULT; AGED; BRADYCARDIA; CASE REPORT; DRUG BIOAVAILABILITY; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FOLLOW UP; HOLTER MONITORING; HUMAN; LETTER; MALE; OPEN ANGLE GLAUCOMA; SYNCOPE;

ADRENERGIC BETA-ANTAGONISTS; AGED; BRADYCARDIA; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS;

EID: 0042129882     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Vander Zanden JA, Valuck RJ, Bunch CL, Perlman JI, Anderson C, Wortman GI. Systemic adverse effects of ophthalmic β-blockers. Ann Pharmacother 2001;35:1633-7.
2. Korte JM, Kaila T, Saari KM. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Graefes Arch Clin Exp Ophthalmol 2002;240:430-5.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Ros FE, Dake CL. Timolol eye drops: bradycardia or tachycardia? Doc Ophthalmol 1980;48:283-9.
5. Dickstein K, Hapnes R, Aarsland T. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma. Am J Ophthalmol 2001;132:626-32.
6. Netland PA, Weiss HS, Stewart WC, Cohen JS, Nussbaum LL. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group. Am J Ophthalmol 1997;123:465-77.
7. Hoyng PF, van Beek LM. Pharmacological therapy for glaucoma: a review. Drugs 2000;59:411-34.